AtulyaAchyutDeodharMDMRCP, FACP, FACR
Rheumatology • Portland, ORRheumatoid Arthritis & Related, Spondyloarthropathy
Professor of Medicine, Oregon Health & Science University
Dr. Deodhar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 Sw Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-8637Fax+1 503-494-1133
Education & Training
Oregon Health & Science University (OHSU Health)Fellowship, Rheumatology, 1995 - 1998
B.J. Medical College - University of PuneClass of 1987
Certifications & Licensure
OR State Medical License 1998 - 2025- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Portland Monthly Magazine Castle Connolly, 2011
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 Apr 12
- A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis Start of enrollment: 2016 Aug 02
- A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis Start of enrollment: 2017 May 09
Publications & Presentations
PubMed
- 322 citations2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatme...Michael M Ward, Atul Deodhar, Lianne S Gensler, Maureen Dubreuil, David Yu
Arthritis Care & Research. 2019-10-01 - 18 citationsPersistence of Staphylococcus aureus colonization among individuals with immune-mediated inflammatory diseases treated with TNF-α inhibitor therapyCara D. Varley, Atul Deodhar, Benjamin D. Ehst, Antony C. Bakke, Andrew Blauvelt
Rheumatology. 2014-02-01 - 293 citationsBrodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic ArthritisPhilip J. Mease, Mark C. Genovese, Maria Greenwald, Christopher T. Ritchlin, André D. Beaulieu
The New England Journal of Medicine. 2014-06-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
